VIP
IDXX icon

Vantage Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Vantage Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.4M Sell
54,067
-35
-0.1% -$22.4K 2.1% 21
2025
Q4 		$36.6M Sell
54,102
-2,605
-5% -$1.77M 2.44% 18
2025
Q3 		$36.2M Sell
56,707
-8,058
-12% -$4.89M 2.48% 19
2025
Q2 		$34.7M Buy
64,765
+11,548
+22% +$5.52M 2.53% 18
2025
Q1 		$22.3M Buy
+53,217
New +$23.1M 1.88% 21

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vantage Investment Partners's IDXX Position: Q1 2026 in Review

Vantage Investment Partners reduced its Idexx Laboratories (IDXX) stake by 0.06% in Q1 2026, selling an estimated $22.4K and leaving 54,067 shares worth $30.4M. The position accounts for 2.1% of the portfolio, ranked #21.

Vantage Investment Partners first reported a position in IDXX in Q1 2025 and has held it in 5 quarters since. The position peaked at $36.6M in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Vantage Investment Partners held 54,067 shares of Idexx Laboratories worth $30.4M as of Q1 2026.
  • Vantage Investment Partners sold 35 Idexx Laboratories shares in Q1 2026, an estimated $22.4K.
  • Idexx Laboratories made up 2.1% of Vantage Investment Partners's portfolio in Q1 2026, its #21 holding.
  • Vantage Investment Partners first reported a position in Idexx Laboratories in Q1 2025 and has held it in 5 quarters since.
  • Vantage Investment Partners's Idexx Laboratories position peaked at $36.6M in Q4 2025.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Vantage Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.